Free Trial

IM Cannabis Q3 2023 Earnings Report

IM Cannabis logo
$2.08 +0.08 (+4.00%)
(As of 12/20/2024 05:31 PM ET)

IM Cannabis EPS Results

Actual EPS
-$0.72
Consensus EPS
-$0.96
Beat/Miss
Beat by +$0.24
One Year Ago EPS
N/A

IM Cannabis Revenue Results

Actual Revenue
$12.37 million
Expected Revenue
$9.85 million
Beat/Miss
Beat by +$2.52 million
YoY Revenue Growth
N/A

IM Cannabis Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

⭕ [URGENT] Buy Alert just triggered (Ad)

My absolute favorite stock just hit a critical "buy now" trigger price.

Click here for the ticker >>>

IM Cannabis Earnings Headlines

IM Cannabis Corp Raises Funds Amid Global Challenges
IM Cannabis Corp. (IMCC) Q3 2024 Earnings Call Transcript
Could This Tiny Device Help You Make an Extra $30k a Year?
I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.
IM Cannabis Reports Third Quarter Financial Results
See More IM Cannabis Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like IM Cannabis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on IM Cannabis and other key companies, straight to your email.

About IM Cannabis

IM Cannabis (NASDAQ:IMCC) engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.

View IM Cannabis Profile

More Earnings Resources from MarketBeat

Upcoming Earnings